3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Endometrial Neoplasms
6
Lymphatic Metastasis
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Clinical Stage I Gastric Cancer AJCC v8
2
Carcinoma, Transitional Cell
2
Vulvar Neoplasms
1
Urologic Neoplasms
1
Ureteral Neoplasms
1
Recurrence
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Ovarian Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Mixed Tumor, Mesodermal
1
Melanoma
1
Lymphedema
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Disease
1
Cholangiocarcinoma
1
Interventions
Radiotherapy
29
Cisplatin
12
Amifostine
11
Radiotherapy, Intensity-Modulated
7
Paclitaxel
7
Carboplatin
7
Etoposide
5
Radiosurgery
4
Donepezil
4
Brachytherapy
4
Bevacizumab
4
sargramostim
3
Surgical Procedures, Operative
3
Mental Status and Dementia Tests
3
Filgrastim
3
Diet Therapy
3
Blood Specimen Collection
3
Radiation Dose Hypofractionation
2
Radiation
2
Proton Therapy
2
Magnetic Resonance Spectroscopy
2
Low-Level Light Therapy
2
Lithium
2
Hyperbaric Oxygenation
2
Heavy Ion Radiotherapy
2
Fluorouracil
2
Fibroblast Growth Factor 7
2
Dexamethasone
2
Chemotherapy, Adjuvant
2
Androgen Antagonists
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Radiation Injuries
×
Lymph Node Excision
×
Clear all
NCT04889924
2026-05-19
ADARNAT
Hospital Universitari de Bellvitge
Phase NA
Recruiting
820 enrolled